13G Filing: Tappan Street Partners and Peregrine Pharmaceuticals Inc (PPHM)
You can access the original SEC filing by clicking here.
Hedge Fund - Tappan Street Partners
Get Email AlertsPrasad Phatak And Chris Koranda Bio, Returns, AUM, Net Worth
Manager biography is currently missing.
Fund Profile
Filing Period:
| Fund Name: | Tappan Street Partners |
| Manager | Prasad Phatak And Chris Koranda |
| Portfolio Value | $35,696,000 |
| Change This QTR | +1.04% |
Top 13F Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Security | Ticker | Shares | Value | Activity | % Port | History |
|---|---|---|---|---|---|---|---|
| 1. | PPHM | 2,871,000 | $9,015,000 | NEW | 25.25% | ||
| 2. | ADNT | 90,000 | $7,559,000 | -15% | 21.17% | ||
| 3. | VOYA | 165,000 | $6,582,000 | 18.43% | |||
| 4. | HIL | 930,000 | $4,418,000 | +4% | 12.37% | ||
| 5. | HDSN | 466,501 | $3,643,000 | -16% | 10.2% |
Latest 13D & 13G Filings
| Symbol | Company | Filed By | Filing Date | Filing |
|---|---|---|---|---|
| 2021-10-28 | ||||
| 2021-02-12 | ||||
| 2020-02-14 | ||||
| 2019-02-14 | ||||
| 2018-02-14 |
News, Interviews and Investor Letters
13G Filing: Tappan Street Partners and Peregrine Pharmaceuticals Inc (PPHM)
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the...
